SAN DIEGO, Oct. 31, 2017 /PRNewswire/ -- Orexigen
Therapeutics, Inc. (Nasdaq: OREX) will announce corporate and
financial results for the third quarter of 2017 on Monday, November 13th after the market
closes. Following the announcement, Orexigen will provide a
business update and discuss the financial results in a live webcast
and conference call at 5:00 p.m. Eastern
Time (2:00 p.m. Pacific
Time).
The live call may be accessed by phone by calling (800) 708-4539
(domestic) or (847) 619-6396 (international), participant code
45886353. The webcast can be accessed live on the "Investors"
section of the Orexigen web site at www.orexigen.com, and will be
archived for 14 days following the call.
Orexigen Contact:
Jason Keyes
Chief Financial Officer
Orexigen Therapeutics, Inc.
+1-858-875-8600
jkeyes@orexigen.com
Media Contact:
Erika Hackmann
Y&R
+1-917-538-3375
erika.hackmann@yr.com
View original
content:http://www.prnewswire.com/news-releases/orexigen-therapeutics-to-provide-business-update-and-discuss-third-quarter-2017-financial-results-on-november-13-2017-300546934.html
SOURCE Orexigen Therapeutics, Inc.